1-11 of 11
Yanliang Bai
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Homoharringtonine Combining with Azacitidine and Venetoclax (HAV) As First-Line Induction Therapy for Newly Diagnosed Adult Acute Myeloid Leukemia Patients

Wenyi Lu, Xiangli Chen, Yuzhu Zang, Zunmin Zhu, Wenhui Zhang, Yanliang Bai, Yuqing Chen, Li Jiang, Yanyan Xing, Yuanbo Liu, Jie Shi, Zhenxing Gao
Journal: Blood
Blood (2024) 144 (Supplement 1): 6037.
https://doi.org/10.1182/blood-2024-203408
Published: 2024
Journal Articles

Venetoclax Combined with Three-Day Multi-Frequency Decitabine (DEC3-VEN) VS Venetoclax Combined with Azacitidine in Elderly Patients with Acute Myeloid Leukemia：a Phase III, Prospective, Multicenter, Randomized Controlled Trial

ZePing Zhou, Yaxian Tan, Xingli Zhao, Xiaohui Suo, Guanchen Bai, Yanliang Bai, Yunya Luo, Xinxiao Lu, Linyu Yuan, Congcong Zhang, Yinling Li, Sifeng Gao, Jilei Zhang, Hongling Peng, Pengxiang Guo, Yingchang Mi, Kaiqi Liu
Journal: Blood
Blood (2024) 144 (Supplement 1): 6035.
https://doi.org/10.1182/blood-2024-202495
Published: 2024
Journal Articles

Venetoclax Combined with Intensive Chemotherapy As an Induction Chemotherapy in Newly Diagnosed FLT3-ITD Positive AML

Yuyu Liu, Guanchen Bai, Xingli Zhao, Xiaohui Suo, Yanliang Bai, Weihua Zhao, Hongling Peng, Fang Zheng, Dongmei Wang, Liyun Zhao, Jie Liu, Ling Li, Xinxiao Lu, Congcong Zhang, Zeyan Shi, Yunya Luo, Xuemei Zhao, Yaxian Tan, ZePing Zhou, Pengxiang Guo, Yingchang Mi, Kaiqi Liu
Journal: Blood
Blood (2024) 144 (Supplement 1): 1485.
https://doi.org/10.1182/blood-2024-203422
Published: 2024
Journal Articles

7-Day Venetoclax Combined with Intensive Chemotherapy As Induction Treatment in Newly Diagnosed Acute Myeloid Leukemia

Ting Liu, Xingli Zhao, Xiaohui Suo, Guanchen Bai, Yanliang Bai, Weihua Zhao, Hongling Peng, Fang Zheng, Dongmei Wang, Liyun Zhao, Jie Liu, Ling Li, Xinxiao Lu, Congcong Zhang, Sifeng Gao, Zeyan Shi, Yunya Luo, Xuemei Zhao, Yaxian Tan, ZePing Zhou, Pengxiang Guo, Yingchang Mi, Kaiqi Liu
Journal: Blood
Blood (2024) 144 (Supplement 1): 2885.
https://doi.org/10.1182/blood-2024-198844
Published: 2024
Journal Articles

Venetoclax Combined with Three-Day Multi-Frequency Decitabine and Homoharringtonine (DEC3-VEN-HHT) As Induction Therapy in Newly Diagnosed Core-Binding Factor Acute Myeloid Leukemia

Lei Ju, Xingli Zhao, Xiaohui Suo, ZePing Zhou, Yanliang Bai, Yunya Luo, Sifeng Gao, Xinxiao Lu, Linyu Yuan, Congcong Zhang, Yinling Li, Yaxian Tan, Guanchen Bai, Hongling Peng, Pengxiang Guo, Yingchang Mi, Kaiqi Liu
Journal: Blood
Blood (2024) 144 (Supplement 1): 1505.
https://doi.org/10.1182/blood-2024-202971
Published: 2024
Journal Articles

Venetoclax Combined with Three-Day Multi-Frequency Decitabine (DEC3-VEN) in the Treatment of Adult Patients with De Novo Acute Myeloid Leukemia

ZePing Zhou, Yaxian Tan, Xingli Zhao, Xiaohui Suo, Guanchen Bai, Yanliang Bai, Yunya Luo, Xinxiao Lu, Linyu Yuan, Congcong Zhang, Yinling Li, Sifeng Gao, Jilei Zhang, Hongling Peng, Pengxiang Guo, Yingchang Mi, Kaiqi Liu
Journal: Blood
Blood (2024) 144 (Supplement 1): 4279.
https://doi.org/10.1182/blood-2024-202430
Published: 2024
Journal Articles

A predictive model for therapy failure in patients with chronic myeloid leukemia receiving tyrosine kinase inhibitor therapy

Clinical Trials & Observations
Xiaoshuai Zhang, Bingcheng Liu, Jian Huang, Yanli Zhang, Na Xu, Robert Peter Gale, Weiming Li, Xiaoli Liu, Huanling Zhu, Ling Pan, Yunfan Yang, Hai Lin, Xin Du, Rong Liang, Chunyan Chen, Xiaodong Wang, Guohui Li, Zhuogang Liu, Yanqing Zhang, Zhenfang Liu, Jianda Hu, Chunshui Liu, Fei Li, Wei Yang, Li Meng, Yanqiu Han, Li’e Lin, Zhenyu Zhao, Chuanqing Tu, Caifeng Zheng, Yanliang Bai, Zeping Zhou, Suning Chen, Huiying Qiu, Lijie Yang, Xiuli Sun, Hui Sun, Li Zhou, Zelin Liu, Danyu Wang, Jianxin Guo, Liping Pang, Qingshu Zeng, Xiaohui Suo, Weihua Zhang, Yuanjun Zheng, Xiaojun Huang, Qian Jiang
Journal: Blood
Blood (2024) 144 (18): 1951–1961.
https://doi.org/10.1182/blood.2024024761
Published: 2024
Includes: Supplemental data
Journal Articles

Low Erythropoietin to Albumin Ratio in the Serum Predicts Less Reversibility of Renal Impairment with Poorer Prognosis in Multiple Myeloma

Kai Sun, Ying Liu, Yanliang Bai, Haoyan Wang, Mengzhen Wang, Yuan Chen, Li Bao
Journal: Blood
Blood (2023) 142 (Supplement 1): 6681.
https://doi.org/10.1182/blood-2023-182670
Published: 2023
Journal Articles

H3K36 Trimethylation Mediated By SETD2 Regulates Cell Proliferation and Cell Cycle By Modulating BCMA-JNK and c-Myc Pathways in Multiple Myeloma

Pan Zhou, Mengyu Xiao, Yanliang Bai, Huixia Cao, Weiping Yuan, Fengmin Shao, Kai Sun
Journal: Blood
Blood (2021) 138 (Supplement 1): 2200.
https://doi.org/10.1182/blood-2021-145120
Published: 2021
Journal Articles

Allogeneic CAR-T Cell Therapy for Treatment of Relapse after Allo-HSCT in Patients with Refractory CML Lymphoid Blast Crisis: Significance of HLA Matched Donor/Patient Pair in the Safety/Efficacy of CAR-T Cell Therapy

Kai Sun, MD, Xuejun Zhang, MD, Zhen Wang, MD, Yuqing Chen, MD, Lei Zhang, MD, Wei Cheng, MD, Mingyue Shi, MD, Lei Huo, MD, Yanliang Bai, MD, Xiaona Niu, MD, Honggang Guo, MD, Jing Yang, MD, Chunrong Tong, MD, AlexH Chang, MD, PhD
Journal: Blood
Blood (2018) 132 (Supplement 1): 4275.
https://doi.org/10.1182/blood-2018-99-115768
Published: 2018
Journal Articles

The Value of FDP/FIB and D-Dimer/FIB Ratios: Predicting High-Risk APL Related Thrombosis

Yanliang Bai, MD, Mingyue Shi, MD, Wanjun Zhang, MD, Xiawan Yang, MD, Hafiz Abdul Waqas Ahmed, MD, Lei Huo, MD, Yuqing Chen, MD, Xiaona Niu, MD, Honggang Guo, MD, Fangfang Xu, MD, PhD, Jing Yang, MD, Yuzhu Zang, MD, Shuangyin Han, MD, PhD, Kai Sun, MD
Journal: Blood
Blood (2018) 132 (Supplement 1): 5010.
https://doi.org/10.1182/blood-2018-99-113453
Published: 2018